[Story Summary]
-
Affordable Care, a leading DSO with 425 locations, is currently restructuring $1.4 billion in private-credit debt with lenders like Blackstone and KKR following a significant decline in earnings.
-
Consumer Spending & Confidence: High interest rates and general inflation have severely curtailed consumer appetite for high-ticket, out-of-pocket dental expenses, as patients prioritize essential living costs over discretionary tooth-replacement services.
-
Sector Impact: This event signals a critical "stress test" for the dental industry’s private-equity-backed model; it highlights the vulnerability of DSOs that rely on high leverage and elective procedures, forcing a shift in the broader market toward valuation discipline, cash-flow stability, and operational efficiency over pure horizontal expansion.
[What it means for practice owners]
-
Vulnerability of Elective "Big-Ticket" Cases: Practice owners specializing in implants, full-mouth reconstructions (Invisalign/Cosmetic), or cash-pay models must prepare for continued volatility. Unlike hygiene and insurance-based restorative work, these procedures are highly sensitive to credit card rates and household budget squeezes, leading to extended treatment plan acceptance cycles.
-
End of the "Easy Money" Era: For owners looking to exit or partner with a DSO, the days of astronomical double-digit multiples fueled by cheap debt are receding. Buyers are now prioritizing EBITDA quality and labor cost management (specifically hygienist and support staff wages) over aggressive growth projections.
-
Operational Tightening: If your practice is under a DSO umbrella, expect a pivot toward cost-discipline mandates. This may include more rigorous oversight of supply procurement, staffing ratios, and a shift in marketing spend toward high-ROI patient acquisition rather than brand awareness.
-
Market Consolidation Shift: While acquisitions continue, the "flight to quality" means independent practices with strong, recurring insurance-based revenue and low debt will command a premium, while highly leveraged or elective-heavy platforms may face restructuring or "down rounds" in valuation.
[Story]
MORRISVILLE, N.C. — Affordable Care, one of the nation’s largest dental-service organizations and a specialist in tooth-replacement procedures, has defaulted on a $1.4 billion private-credit loan and is negotiating a debt restructuring with its lenders, including Blackstone Inc. and KKR & Co., people familiar with the matter said.
The talks, which began in recent weeks, mark the latest sign of strain in the $2 trillion private-credit market, where funds extended large loans to finance private-equity buyouts at a time of low interest rates and soaring valuations. For Affordable Care, the debt load — layered on during its 2021 acquisition — has become unsustainable as earnings have deteriorated amid higher borrowing costs and softer consumer demand for elective dental work.
The company, founded in 1975 and headquartered here in North Carolina’s Research Triangle, provides nonclinical support to roughly 425 affiliated dental practices across about 40 states. Its flagship brands — Affordable Dentures & Implants, Advanced Dental Implant Center and DDS Dentures + Implant Solutions — focus almost exclusively on dentures and implants. Many procedures are paid out of pocket, shielding the business from insurance reimbursement pressures that have squeezed other dental groups. Yet that same model has left it exposed to economic uncertainty: patients have delayed costly tooth-replacement work as inflation and higher interest rates crimped discretionary spending.
Harvest Partners, a New York-based private-equity firm, bought Affordable Care in August 2021 from Berkshire Partners in a deal valued at about $2.7 billion. The transaction was financed in part with more than $1.4 billion in private credit, a loan arranged by KKR and held in largest part by Blackstone. Other participants include Antares Capital and New Mountain Capital.
The financing reflected the era’s easy-money conditions. Private-equity firms poured capital into dental-service organizations, or DSOs, betting that centralized management, marketing muscle and economies of scale would deliver steady cash flows from an aging population in need of dental care. Affordable Care had grown rapidly under Berkshire, tripling in size after adding brands such as DDS Dentures + Implant Solutions in 2019.
But the environment shifted. The Federal Reserve’s aggressive rate hikes beginning in 2022 pushed up the cost of the floating-rate debt. By January, Affordable Care had hired turnaround specialists at AlixPartners to advise on its finances, according to people with knowledge of the engagement. Earnings continued to slip, prompting lenders to begin marking down the loan’s value.
In its first-quarter regulatory filing, Blackstone’s flagship private-credit vehicle, BCRED, wrote the loan down to 70 cents on the dollar, from about 80 cents at year-end. Other lenders showed more optimistic marks in the fourth quarter — Antares at 96 cents, KKR at 93 cents — but the gap underscored growing concern. The markdown, together with a larger write-down on a loan to software maker Medallia, helped push BCRED’s nonperforming loan ratio to a record 2.4 percent of its $80.5 billion portfolio.
Blackstone described the exposure as modest. “Affordable Care represents a fraction of one percent of the fair value of our BDC portfolios,” the firm said in a statement. “We first marked down the loan 18 months ago and continue to be proactive in addressing underperformers across our portfolio. We are well-positioned to utilize Blackstone’s resources and capabilities to seek to maximize recoveries for our shareholders.”
KKR declined to comment. Harvest Partners did not respond to requests for comment.
The restructuring talks are still fluid. Lenders are weighing options that could include extending maturities, swapping some debt for equity or injecting fresh capital, according to people briefed on the discussions. A full bankruptcy filing has not occurred, and the company continues to operate its network of practices.
The episode highlights broader challenges rippling through the DSO sector and the private-credit market that helped finance its expansion. Many dental groups entered the pandemic with heavy debt loads. While volumes rebounded in 2022 and 2023 with the help of federal relief funds, the recovery proved uneven. Staffing shortages, rising supply costs and cautious patients have weighed on margins industrywide. Affordable Care’s focus on higher-margin elective procedures once looked like a strength; now it appears a vulnerability.
Private-equity ownership of dental practices has drawn scrutiny from regulators and dentists’ groups, who worry that cost-cutting and aggressive upselling can compromise care. Yet defenders note that DSOs have brought modern management, digital tools and expanded access to markets that once lacked specialized implant services.
For now, the immediate stakes are financial. Blackstone and KKR, two of Wall Street’s largest alternative-asset managers, have built enormous private-credit franchises on the promise of steady yields and low defaults. Isolated problems like Affordable Care’s — and Medallia’s — have not yet threatened the broader market. But they illustrate how quickly leverage can turn problematic when economic conditions change.
Affordable Care’s lenders are betting that the company’s national footprint and specialized focus still hold value. Whether patients return for implants and dentures as the economy stabilizes will help determine how much of that $1.4 billion is ultimately recovered.
What happens next will be watched closely by other private-credit investors holding healthcare debt. Restructuring terms set here could influence negotiations elsewhere in the sector, where similar leveraged buyouts from the 2021 boom are coming due. For Affordable Care’s affiliated dentists and the patients they serve, the outcome will shape whether the business emerges leaner and more stable — or changes hands under new ownership altogether.
The company’s website still promotes its mission: “Everyone deserves to love their teeth.” Delivering on that promise while servicing its creditors will test the limits of the private-equity model that built it.